scholarly article | Q13442814 |
P356 | DOI | 10.1006/VIRO.1996.0479 |
P8608 | Fatcat ID | release_uj6acevgbvaxpbg23lrislwzji |
P698 | PubMed publication ID | 8806563 |
P5875 | ResearchGate publication ID | 14397452 |
P50 | author | Eliezer Masliah | Q28324209 |
Daniel Gonzalez-Dunia | Q42412983 | ||
P2093 | author name string | Mallory M | |
Hansen LA | |||
Mueller-Lantzsch N | |||
Grässer FA | |||
Cubitt B | |||
De La Torre JC | |||
P433 | issue | 2 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | autopsy | Q41482 |
Borna disease | Q9430213 | ||
P304 | page(s) | 272-282 | |
P577 | publication date | 1996-09-01 | |
P1433 | published in | Virology | Q7934867 |
P1476 | title | Detection of borna disease virus antigen and RNA in human autopsy brain samples from neuropsychiatric patients | |
P478 | volume | 223 |
Q39683783 | 1-beta-D-arabinofuranosylcytosine inhibits borna disease virus replication and spread. |
Q36544916 | A reverse-type sandwich enzyme-linked immunosorbent assay for detecting antibodies to Borna disease virus |
Q33938504 | Amantadine in depressive patients with Borna disease virus (BDV) infection: an open trial |
Q38469008 | Antiretroviral antibodies: implications for schizophrenia, schizophrenia spectrum disorders, and bipolar disorder. |
Q89746499 | Antiviral treatment perspective against Borna disease virus 1 infection in major depression: a double-blind placebo-controlled randomized clinical trial |
Q37737132 | Blue moon neurovirology: the merits of studying rare CNS diseases of viral origin |
Q37064150 | Borna disease |
Q33674718 | Borna disease in a dog with lethal meningoencephalitis |
Q34204866 | Borna disease virus (BDV) infection in psychiatric patients and healthy controls in Iran |
Q41092612 | Borna disease virus P-protein is phosphorylated by protein kinase Cepsilon and casein kinase II. |
Q34296879 | Borna disease virus and human disease |
Q45736661 | Borna disease virus and neuropsychiatric disease--a reappraisal |
Q45760731 | Borna disease virus and neuropsychiatric disorders. The Japan Bornavirus Study Group |
Q41676181 | Borna disease virus and the brain. |
Q36067943 | Borna disease virus and the evidence for human pathogenicity: a systematic review |
Q34419929 | Borna disease virus antibodies and the deficit syndrome of schizophrenia. |
Q40132968 | Borna disease virus glycoprotein is required for viral dissemination in neurons. |
Q41585181 | Borna disease virus infection in animals and humans |
Q38183555 | Borna disease virus infection in cats. |
Q34547799 | Borna disease virus infection in psychiatric patients: are we on the right track? |
Q24670050 | Borna disease virus infection, a human mental-health risk |
Q33787231 | Borna disease virus persistence causes inhibition of glutamate uptake by feline primary cortical astrocytes |
Q31552307 | Borna disease virus persistent infection activates mitogen-activated protein kinase and blocks neuronal differentiation of PC12 cells. |
Q45752355 | Borna disease virus proteins in cerebrospinal fluid of patients with recurrent depression and multiple sclerosis |
Q34265129 | Borna disease virus--does it infect humans and cause psychiatric disorders? |
Q45749950 | Borna disease virus-induced hippocampal dentate gyrus damage is associated with spatial learning and memory deficits |
Q34176593 | Borna disease virus. |
Q38777663 | Brain cytokines and disease |
Q38559106 | Characterization of Borna disease virus p56 protein, a surface glycoprotein involved in virus entry |
Q45749720 | Cytokine expression in the rat central nervous system following perinatal Borna disease virus infection |
Q34306673 | DNA immunization and central nervous system viral infection |
Q24523700 | Detection and sequence analysis of borna disease virus p24 RNA from peripheral blood mononuclear cells of patients with mood disorders or schizophrenia and of blood donors |
Q33788598 | Detection by radioligand assay of antibodies against Borna disease virus in patients with various psychiatric disorders. |
Q45759404 | Detection of Borna disease virus genome in normal human brain tissue |
Q44433920 | Detection of anti-Borna Disease Virus (BDV) antibodies from patients with schizophrenia and mood disorders in Japan |
Q39506549 | Detection of borna disease virus-reactive antibodies from patients with psychiatric disorders and from horses by electrochemiluminescence immunoassay. |
Q42202279 | Human borna disease virus infection impacts host proteome and histone lysine acetylation in human oligodendroglia cells |
Q28245161 | Human herpesvirus-6 entry into the central nervous system through the olfactory pathway |
Q33454005 | Intracerebral Borna disease virus infection of bank voles leading to peripheral spread and reverse transcription of viral RNA |
Q45665128 | Investigation of frequency of active Borna disease virus infection in Scottish blood donors |
Q39591476 | Isolation and characterization of a new subtype of Borna disease virus |
Q33804447 | Isolation of Borna disease virus from human brain tissue |
Q43590759 | Low avidity of human serum antibodies for Borna disease virus antigens questions their diagnostic value |
Q39577476 | Mechanism of Borna disease virus entry into cells |
Q24529164 | N-terminal domain of Borna disease virus G (p56) protein is sufficient for virus receptor recognition and cell entry |
Q34993101 | Neuronal survival strategies in the face of RNA viral infection. |
Q35095721 | Neuropharmacological sequelae of persistent CNS viral infections: lessons from Borna disease virus |
Q44775042 | No Borna disease virus-specific RNA detected in blood from psychiatric patients in different regions of Germany. The Bornavirus Study Group |
Q36203757 | Olfactory transmission of neurotropic viruses |
Q45753731 | Persistence of Borna disease virus-specific nucleic acid in blood of psychiatric patient |
Q45747266 | Persistent Borna disease virus infection of neonatal rats causes brain regional changes of mRNAs for cytokines, cytokine receptor components and neuropeptides |
Q36181494 | Primary psychosis and Borna disease virus infection in Lithuania: a case control study |
Q33945106 | Research and treatment approaches to depression |
Q45411574 | Reverse transcription real-time PCR assays for detection and quantification of Borna disease virus in diseased hosts |
Q28249580 | Rodent-borne diseases and their risks for public health |
Q45755503 | Sensitivity and reproducibility of RT-PCR to detect Borna disease virus (BDV) RNA in blood: implications for BDV epidemiology |
Q33801840 | Synaptic pathology in Borna disease virus persistent infection. |
Q36432628 | T cell ignorance in mice to Borna disease virus can be overcome by peripheral expression of the viral nucleoprotein |
Q91654356 | The equine species as Trojan horse for Borna Disease Virus-1? |
Q40855823 | The mechanism of actinomycin D-mediated increase of Borna disease virus (BDV) RNA in cells persistently infected by BDV. |
Q34976792 | Two Major Histocompatibility Complex Class I-Restricted Epitopes of the Borna Disease Virus p10 Protein Identified by Cytotoxic T Lymphocytes Induced by DNA-Based Immunization |
Q33923675 | Use of the autopsy to study ontogeny and expression of the estrogen receptor gene in human breast |
Q24523159 | Virus-specific CD4+ T cells eliminate borna disease virus from the brain via induction of cytotoxic CD8+ T cells |